相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JAK inhibition as a therapeutic strategy for immune and inflammatory diseases (vol 16, pg 843, 2017)
Daniella M. Schwartz et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Distinct Effects of IL-6 Classic and Trans-Signaling in Bone Fracture Healing
Katja Prystaz et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
IL-6 Trans-Signaling Is Essential for the Development of Hepatocellular Carcinoma in Mice
Juri Bergmann et al.
HEPATOLOGY (2017)
IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H-pylori in mice
M. Moyat et al.
MUCOSAL IMMUNOLOGY (2017)
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Sylvia Heink et al.
NATURE IMMUNOLOGY (2017)
The role and therapeutic targeting of IL-6 in rheumatoid arthritis
Masashi Narazaki et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
IL-6 Regulates M2 Polarization and Local Proliferation of Adipose Tissue Macrophages in Obesity
Julia Braune et al.
JOURNAL OF IMMUNOLOGY (2017)
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Severine Vermeire et al.
LANCET (2017)
Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study
Daniel Aletaha et al.
LANCET (2017)
Novel treatment strategies in rheumatoid arthritis
Gerd R. Burmester et al.
LANCET (2017)
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Roy Fleischmann et al.
LANCET (2017)
The emerging safety profile of JAK inhibitors in rheumatic disease (vol 13, pg 234, 2017)
Kevin L. Winthrop
NATURE REVIEWS RHEUMATOLOGY (2017)
The role of IL-6 in host defence against infections: immunobiology and clinical implications
Stefan Rose-John et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Trial of Tocilizumab in Giant-Cell Arteritis
J. H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Peter C. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis
Koji Taniguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
THE CHALLENGES OF RARE RHEUMATIC DISEASESI79. CHALLENGES OF DIAGNOSING AND MANAGING PATIENTS WITH RARE DISEASES
Robert Moots
RHEUMATOLOGY (2017)
Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance
Elaine Xu et al.
NATURE COMMUNICATIONS (2017)
Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
Steffen Riethmueller et al.
PLOS BIOLOGY (2017)
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Roy Fleischmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti et al.
ONCOIMMUNOLOGY (2017)
Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities
Marcin Kortylewski et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
Ingo Kleiter et al.
NEUROTHERAPEUTICS (2016)
Follicular Helper T Cells
Carola G. Vinuesa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Immunotherapeutic implications of IL-6 blockade for cytokine storm
Toshio Tanaka et al.
IMMUNOTHERAPY (2016)
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Peter M. Villiger et al.
LANCET (2016)
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial
J. J. Shah et al.
BLOOD CANCER JOURNAL (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
Philip J. Mease et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Mark C. Genovese et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy
Joel M. Kremer et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
Brad H. Rovin et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Idiopathic multicentric Castleman's disease: a systematic literature review
Amy Y. Liu et al.
LANCET HAEMATOLOGY (2016)
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
Michael J. Kraakman et al.
CELL METABOLISM (2015)
Family reunion - A structured view on the composition of the receptor complexes of interleukin-6-type and interleukin-12-type cytokines
Stefan Rose-John et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Interleukin-6: Biology, signaling and strategies of blockade
Fred Schaper et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
Marine Lacroix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production
Konstantia-Maria Chavele et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
Nike Mueller et al.
JOURNAL OF LIPID RESEARCH (2015)
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W. Lee et al.
LANCET (2015)
A gp130-Src-YAP module links inflammation to epithelial regeneration
Koji Taniguchi et al.
NATURE (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
FDA-approved small-molecule kinase inhibitors
Peng Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
Maarten Van Roy et al.
ARTHRITIS RESEARCH & THERAPY (2015)
The Efficacy and Safety of Subcutaneous Clazakizumab in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Michael E. Weinblatt et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)
Clifton O. Bingham et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Therapeutic uses of anti-interleukin-6 receptor antibody
Sujin Kang et al.
INTERNATIONAL IMMUNOLOGY (2015)
Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study
Mark C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
Christoph Garbers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Molecular Pathways: Molecular Basis for Sensitivity and Resistance to JAK Kinase Inhibitors
Sara C. Meyer et al.
CLINICAL CANCER RESEARCH (2014)
Type I IFN Induces Binding of STAT1 to Bcl6: Divergent Roles of STAT Family Transcription Factors in the T Follicular Helper Cell Genetic Program
Shingo Nakayamada et al.
JOURNAL OF IMMUNOLOGY (2014)
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
James D. Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Frits van Rhee et al.
LANCET ONCOLOGY (2014)
Discovery and characterization of olokizumab A humanized antibody targeting interleukin-6 and neutralizing gp130-signaling
Stevan Shaw et al.
MABS (2014)
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
Jan Mauer et al.
NATURE IMMUNOLOGY (2014)
Regulatory B cells are induced by gut microbiota-driven interleukin-1β and interleukin-6 production
Elizabeth C. Rosser et al.
NATURE MEDICINE (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica A pilot study
Manabu Araki et al.
NEUROLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis
Kensuke Kume et al.
RHEUMATOLOGY (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
IL-6 in Inflammation, Immunity, and Disease
Toshio Tanaka et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Safety and Pharmacokinetics of Olokizumab, an Anti-IL-6 Monoclonal Antibody, Administered to Healthy Male Volunteers: A Randomized Phase I Study
Kosmas Kretsos et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2014)
Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus
Yuko Shirota et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Janus kinase inhibitors in autoimmune diseases
John J. O'Shea et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis
Aart C. Strang et al.
ATHEROSCLEROSIS (2013)
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Peter M. Voorhees et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Targeting gp130 to prevent inflammation and promote insulin action
M. J. Kraakman et al.
DIABETES OBESITY & METABOLISM (2013)
An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer
Christoph Garbers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality
Hong Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Judith Hoge et al.
JOURNAL OF IMMUNOLOGY (2013)
STAT-3 Activation by Differential Cytokines Is Critical for Human In Vivo-Generated Plasma Cell Survival and Ig Secretion
Beatriz Rodriguez-Bayona et al.
JOURNAL OF IMMUNOLOGY (2013)
Cutting Edge: STAT1 Is Required for IL-6-Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation
Youn Soo Choi et al.
JOURNAL OF IMMUNOLOGY (2013)
Preclinical Characterization of GLPG0634, a Selective Inhibitor of JAK1, for the Treatment of Inflammatory Diseases
Luc Van Rompaey et al.
JOURNAL OF IMMUNOLOGY (2013)
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay et al.
LANCET (2013)
Therapeutic modulators of STAT signalling for human diseases
Gabriella Miklossy et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
Yunbao Pan et al.
PLOS ONE (2013)
A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
P. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Therapeutic Targeting of the Interleukin-6 Receptor
Toshio Tanaka et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Bharat B. Aggarwal et al.
BLOOD (2012)
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
Jan Suthaus et al.
BLOOD (2012)
A Validated Regulatory Network for Th17 Cell Specification
Maria Ciofani et al.
CELL (2012)
Plasticity and cross-talk of Interleukin 6-type cytokines
Christoph Garbers et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2012)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
Therapeutic targeting of interleukin-6 trans-signaling does not affect the outcome of experimental tuberculosis
Jan Sodenkamp et al.
IMMUNOBIOLOGY (2012)
IL-6 contributes to an immune tolerance checkpoint in post germinal center B cells
Yi Yan et al.
JOURNAL OF AUTOIMMUNITY (2012)
B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1
Alex Karnowski et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Homing and Adhesion Patterns Determine the Cellular Composition of the Bone Marrow Plasma Cell Niche
Elodie Belnoue et al.
JOURNAL OF IMMUNOLOGY (2012)
The interleukin 6 pathway and atherosclerosis
Juergen Scheller et al.
LANCET (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis
Y. H. Lee et al.
LUPUS (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
Ronald F. van Vollenhoven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of infections in rheumatoid arthritis patients treated with tocilizumab
Veronika R. Lang et al.
RHEUMATOLOGY (2012)
When is switching warranted among biologic therapies in rheumatoid arthritis?
Alan Reynolds et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses
Botond Z. Igyarto et al.
IMMUNITY (2011)
Early Th1 Cell Differentiation Is Marked by a Tfh Cell-like Transition
Shingo Nakayamada et al.
IMMUNITY (2011)
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Simon A. Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Long-Lived Plasma Cells from Human Small Intestine Biopsies Secrete Immunoglobulins for Many Weeks In Vitro
Luka Mesin et al.
JOURNAL OF IMMUNOLOGY (2011)
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Kamran Ghoreschi et al.
JOURNAL OF IMMUNOLOGY (2011)
Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
Norio Chihara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection
James A. Harker et al.
SCIENCE (2011)
ADAM17: a molecular switch to control inflammation and tissue regeneration
Juergen Scheller et al.
TRENDS IN IMMUNOLOGY (2011)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease
Soken-Nakazawa J. Song et al.
BLOOD (2010)
Interleukin-6 Signaling in Liver-Parenchymal Cells Suppresses Hepatic Inflammation and Improves Systemic Insulin Action
F. Thomas Wunderlich et al.
CELL METABOLISM (2010)
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
V. B. Matthews et al.
DIABETOLOGIA (2010)
IL-6: from its discovery to clinical applications
Tadamitsu Kishimoto
INTERNATIONAL IMMUNOLOGY (2010)
Autoimmune Disease in Lyn-Deficient Mice Is Dependent on an Inflammatory Environment Established by IL-6
Evelyn Tsantikos et al.
JOURNAL OF IMMUNOLOGY (2010)
Loss of CD4+ T Cell IL-6R Expression during Inflammation Underlines a Role for IL-6 Trans Signaling in the Local Maintenance of Th17 Cells
Gareth W. Jones et al.
JOURNAL OF IMMUNOLOGY (2010)
Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6
Jill E. Chrencik et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi et al.
NATURE (2010)
Genetic epidemiology of age-related osteoporosis and its clinical applications
Ching-Lung Cheung et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
C. J. Edwards et al.
OSTEOPOROSIS INTERNATIONAL (2010)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation
Yongzhong Wu et al.
INTERNATIONAL IMMUNOLOGY (2009)
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Neal K. Williams et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Sandra Rebouissou et al.
NATURE (2009)
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses
Marcin Kortylewski et al.
NATURE BIOTECHNOLOGY (2009)
Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells
Sara Trifari et al.
NATURE IMMUNOLOGY (2009)
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells
Thomas Duhen et al.
NATURE IMMUNOLOGY (2009)
Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
Norihiro Nishimoto et al.
BLOOD (2008)
Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense
Naoko Satoh-Takayama et al.
IMMUNITY (2008)
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells
Matthias Lochner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cutting edge: Soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells
Eva M. Briso et al.
JOURNAL OF IMMUNOLOGY (2008)
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
Josef S. Smolen et al.
LANCET (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
Critical role of ROR-γt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation
Marie-Laure Michel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation
Bjorn Rabe et al.
BLOOD (2008)
IL-22 is expressed by TH17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis
Katharina Kreymborg et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-6 contributes to the expression of RAGS in human mature B cells
Sophie Hillion et al.
JOURNAL OF IMMUNOLOGY (2007)
A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects
S. Rafiq et al.
GENES AND IMMUNITY (2007)
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Yan Zheng et al.
NATURE (2007)
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
Keiji Hirota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
Impaired skeletal development in interleukin-6-transgenic mice - A model for the impact of chronic inflammation on the growing skeletal system
Fabrizio De Benedetti et al.
ARTHRITIS AND RHEUMATISM (2006)
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis
T. P. van Staa et al.
ARTHRITIS AND RHEUMATISM (2006)
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase
Andrew L. Carey et al.
DIABETES (2006)
Signalling and survival pathways in multiple myeloma
Kurt Bommert et al.
EUROPEAN JOURNAL OF CANCER (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
M Veldhoen et al.
IMMUNITY (2006)
Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow
M Shapiro-Shelef et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immune responses and bone loss: the estrogen connection
H Carlsten
IMMUNOLOGICAL REVIEWS (2005)
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease
N Nishimoto et al.
BLOOD (2005)
Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
KI Happel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor
G Skiniotis et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training
BJ Nicklas et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells
H Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Regulation of plasma-cell development
M Shapiro-Shelef et al.
NATURE REVIEWS IMMUNOLOGY (2005)
XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation
AL Shaffer et al.
IMMUNITY (2004)
The Janus kinases (Jaks)
K Yamaoka et al.
GENOME BIOLOGY (2004)
Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex
MJ Boulanger et al.
SCIENCE (2003)
Signaling of human ciliary neurotrophic factor (CNTF) revisited -: The interleukin-6 receptor can serve as an α-receptor for CNTF
B Schuster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Obesity is associated with macrophage accumulation in adipose tissue
SP Weisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
The two faces of IL-6 on Th1/Th2 differentiation
S Diehl et al.
MOLECULAR IMMUNOLOGY (2002)
Cytokines as therapeutic drugs
H Schooltink et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway
JJ O'Shea et al.
CELL (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Interleukin-6 is a growth factor for nonmalignant human plasmablasts
G Jego et al.
BLOOD (2001)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1
S Diehl et al.
IMMUNITY (2000)
Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6
A Steensberg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss
JP Bastard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
分享论文
